The U.S. Food and Drug Administration on Friday proposed to reduce animal studies conducted to assess safety in the development of certain cancer medications, marking the agency’s latest effort to ...
The U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs. “This draft guidance not only ...
During a joint workshop on Monday, officials from the US Food and Drug Administration (FDA) and National Institutes of Health (NIH) outlined efforts to reduce animal testing. FDA Commissioner Marty ...
Pharmaceutical industry groups say they support the US Food and Drug Administration's (FDA) draft guidance on new approach ...
MedPage Today on MSN
FDA sets sights on animal testing; AI privacy threat; chewing gum for cancer?
News, features, and commentary about cancer-related issues ...
The FDA's announcement in April that it will phase out animal testing in clinical trials came as a victory for animal rights activists but garnered mixed reactions among health researchers. The agency ...
Drug developers will be able to use alternatives to animal testing and possibly get new products to market faster under draft guidance issued Wednesday by the FDA. In a press release, officials said ...
Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near future.
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Millions of animals each year are killed in U.S. laboratories as part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results